Pancreatic Cancer Research

ResearcherFondazione PisaActive in the last 2 years

Mjriam Capula

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6445-4437; OpenAlex author ID A5038778703. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2019: 2 papers · 2020: 2 papers · 2021: none · 2022: 5 papers · 2023: 1 paper · 2024: 2 papers

Papers 12

  1. ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. Co-author DOI 10.1186/s13046-023-02879-8↗
  2. Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel. Co-author DOI 10.3390/cancers16223863↗
  3. Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC). Co-author DOI 10.3390/cancers15030628↗
  4. "Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2022.103659↗
  5. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. Co-author DOI 10.1016/j.drup.2022.100864↗
  6. Interrelationship between miRNA and splicing factors in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/15592294.2021.1916697↗
  7. Biodegradable Ultrasmall-in-Nano Architectures Loaded with Cisplatin Prodrug in Combination with Ionizing Radiation Induces DNA Damage and Apoptosis in Pancrea… Co-author DOI 10.3390/cancers14123034↗
  8. Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. Co-author DOI 10.3390/diagnostics12020286↗
  9. Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers. Co-author DOI 10.1007/s13402-020-00548-y↗
  10. Of fungi and men: role of fungi in pancreatic cancer carcinogenesis. First author DOI 10.21037/atm-20-2723↗
  11. New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism. Co-author DOI 10.1080/17512433.2019.1693256↗
  12. A mechanical memory of pancreatic cancer cells First author DOI 10.1101/730960↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elisa Giovannetti · 12 shared papers, 2019–2024 · strength 1.86
  2. Alessandro Gregori · 5 shared papers, 2022–2024 · strength 0.88
  3. Thomas Schmidt · 4 shared papers, 2019–2024 · strength 0.70
  4. Erik H.J. Danen · 3 shared papers, 2023–2024 · strength 0.58
  5. Cecilia Bergonzini · 3 shared papers, 2023–2024 · strength 0.58
  6. Ingrid Garajová · 3 shared papers, 2022–2024 · strength 0.49
  7. Annalisa Comandatore · 3 shared papers, 2022–2023 · strength 0.48
  8. Luca Morelli · 3 shared papers, 2022–2023 · strength 0.48
  9. Benoît Immordino · 2 shared papers, 2022 · strength 0.32
  10. Rita Balsano · 2 shared papers, 2022 · strength 0.32
  11. Dongmei Deng · 2 shared papers, 2020–2022 · strength 0.29
  12. Niccola Funel · 2 shared papers, 2019–2020 · strength 0.24
  13. Asia Botto · 1 shared paper, 2024 · strength 0.18
  14. Liam Andrew McDonnell · 1 shared paper, 2024 · strength 0.18
  15. Fatemeh Khojasteh‐Leylakoohi · 1 shared paper, 2023 · strength 0.16
  16. Amir Avan · 1 shared paper, 2023 · strength 0.16
  17. Macarena Perán · 1 shared paper, 2022 · strength 0.16
  18. Geng Xu · 1 shared paper, 2022 · strength 0.16
  19. Stella Cascioferro · 1 shared paper, 2022 · strength 0.16
  20. I Gede Putu Supadmanaba · 1 shared paper, 2022 · strength 0.16
  21. Ornella Randazzo · 1 shared paper, 2022 · strength 0.16
  22. Godefridus J. Peters · 1 shared paper, 2022 · strength 0.16
  23. Patrizia Diana · 1 shared paper, 2022 · strength 0.16
  24. Umberto Malapelle · 1 shared paper, 2022 · strength 0.15
  25. Pei Pei · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.